Thyroid cancer: open trials in Germany

• NCT07006727

  Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors

  Trial Treatment · Phase 1 · Novartis Pharmaceuticals

  Universitaetsklinikum Essen (AoR), Essen · Klinikum der Technischen Universitaet Muenchen (TUM Klinikum), Munich

  Registry updated 2026-09-22

• NCT05503797

  A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

  Trial Treatment · Phase 2 · Fore Biotherapeutics

  Charite Universitaetsmedizin Berlin KöR, Berlin · Krankenhaus Nordwest GmbH, Frankfurt am Main · Universitaetsklinikum Heidelberg AöR, Heidelberg

  Registry updated 2026-07-27

• NCT03093116

  A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

  Trial Treatment · Phase 1/2 · Turning Point Therapeutics, Inc.

  Technische Universitaet Dresden, Dresden · Universitaetsklinikum Heidelberg AöR, Heidelberg

  Registry updated 2026-05-27

• NCT07410637

  Impact of Thyroid Hormones on Human Glucose and Energy Metabolism

  Trial Treatment · University of Ulm

  Ulm University Hospital, Ulm

  Registry updated 2026-02-13

All Thyroid cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error